Tizona Therapeutics - Ownership and Business Overview

Life ScienceCompany

Tizona Therapeutics Ownership

Who owns Tizona Therapeutics?

Tizona Therapeutics is owned by Gilead Sciences. It was acquired on July 21, 2020.

Tizona Therapeutics Business Overview

Where is Tizona Therapeutics headquartered?

Tizona Therapeutics is headquartered in South San Francisco, California.

What sector is Tizona Therapeutics in?

Tizona Therapeutics is a life science company.

When was Tizona Therapeutics founded?

Tizona Therapeutics was founded in 2015.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 291 acquisitions of life science companies in 2020, including 24 acquisitions by private equity firms, and 267 by strategics.

Tizona Therapeutics, Inc.

4000 Shoreline Court, Suite 200,
South San Francisco, California 94080
United States,
(650) 383-0800
www.tizonatx.com

Tizona Therapeutics is a privately held, clinical-stage immunotherapy company that develops first-in-class medicines to deliver transformational benefits for people with cancer. Tizona translates scientific breakthroughs into therapeutics that stimulate the immune system and counter immune suppression. Its novel pipeline includes the clinical-stage TTX-080, an anti-HLA-G antibody, and a rich preclinical portfolio. Tizona was formed in 2015 and is based in South San Francisco, California.


 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.